Skip Navigation LinksHome > February 2014 - Volume 35 - Issue 2 > Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervi...
Nuclear Medicine Communications:
doi: 10.1097/MNM.0000000000000026
Original Articles

Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis

Chu, Yanxiaa; Zheng, Aia; Wang, Feib; Lin, Weia; Yang, Xiaoyuna; Han, Linga; Chen, Yalia; Bai, Lipinga

Collapse Box

Abstract

Objectives: Accurate detection of recurrent cervical cancer remains a clinical difficulty. This study aims to assess the diagnostic value of PET or PET-computed tomography (PET-CT) using 18F-fluorodeoxyglucose (18F-FDG) in recurrent cervical cancer using a meta-analysis.

Study design: All published studies in English evaluating the diagnostic value of PET or PET-CT in detecting recurrent cervical cancer were collected. The methodological quality of the included studies was evaluated. Pooled sensitivity, specificity, diagnostic odds ratio, and summary receiver-operating characteristic curves were obtained using statistical software. Twenty studies were included in the meta-analysis.

Results: The meta-analysis showed that the pooled sensitivity and specificity of PET and PET-CT to detect distant metastasis in recurrent cervical cancer were 0.87 [95% confidence interval (CI): 0.80–0.92] and 0.97 (95% CI: 0.96–0.98), respectively. The pooled sensitivity and specificity for local regional recurrence were 0.82 (95% CI: 0.72–0.90) and 0.98 (95% CI: 0.96–0.99), respectively.

Conclusion: 18F-FDG-PET and PET-CT are valuable methods for the assessment of recurrent cervical cancer.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.